Oracle Investment Management Inc 13F 持仓 · 最近申报 2025年Q4
Oracle Investment Management 在 2025年Q4（报告期截至 2025-12-31）的 SEC 13F 申报中报告了 18 只证券，申报市值合计 1.68 亿美元。前几大持仓：WGS（68.51%）、ARDX（6.50%）、BHVN（5.19%）。本季前 25 大持仓中：新建仓 8 只、增持 5 只、减持 4 只、清仓 3 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | WGS | GENEDX HOLDINGS CORP | $115.1M | 68.51% | 884,654 | 减持 |
| 2 | ARDX | ARDELYX INC | $10.9M | 6.50% | 1.9M | 增持 |
| 3 | BHVN | BIOHAVEN LTD | $8.7M | 5.19% | 772,181 | 增持 |
| 4 | TDOC | TELADOC HEALTH INC | $4.5M | 2.71% | 650,000 | 增持 |
| 5 | NVAX | NOVAVAX INC | $4.0M | 2.40% | 0 | 新建仓 |
| 6 | ARDX | ARDELYX INC | $3.5M | 2.08% | 600,000 | 减持 |
| 7 | QDEL | QUIDELORTHO CORP | $3.4M | 2.01% | 118,291 | 持平 |
| 8 | FORA | FORIAN INC | $2.9M | 1.72% | 1.4M | 持平 |
| 9 | PSNL | PERSONALIS INC | $2.7M | 1.61% | 339,343 | 增持 |
| 10 | BHVN | BIOHAVEN LTD | $2.6M | 1.57% | 232,900 | 减持 |
| 11 | TDOC | TELADOC HEALTH INC | $2.5M | 1.48% | 354,338 | 减持 |
| 12 | TSHA | TAYSHA GENE THERAPIES INC | $1.5M | 0.87% | 265,000 | 新建仓 |
| 13 | CAVA | CAVA GROUP INC | $1.0M | 0.60% | 17,100 | 持平 |
| 14 | EWTX | EDGEWISE THERAPEUTICS INC | $951,482 | 0.57% | 38,343 | 新建仓 |
| 15 | DAWN | DAY ONE BIOPHARMACEUTICALS I | $932,000 | 0.55% | 100,000 | 新建仓 |
| 16 | PFE | PFIZER INC | $622,500 | 0.37% | 25,000 | 新建仓 |
| 17 | ARKG | ARK ETF TR | $564,915 | 0.34% | 19,500 | 新建仓 |
| 18 | SGMOQ | SANGAMO THERAPEUTICS INC | $435,012 | 0.26% | 1.0M | 增持 |
| 19 | BIIB | BIOGEN INC | $424,488 | 0.25% | 2,412 | 持平 |
| 20 | TEM | TEMPUS AI INC | $384,238 | 0.23% | 6,507 | 新建仓 |
| 21 | TSLA | TESLA INC | $224,860 | 0.13% | 500 | 持平 |
| 22 | HTZ | HERTZ GLOBAL HLDGS INC | $77,100 | 0.05% | 15,000 | 新建仓 |
| 23 | BDSX | BIODESIX INC | $0 | 0.00% | 0 | 清仓 |
| 24 | CNC | CENTENE CORP DEL | $0 | 0.00% | 0 | 清仓 |
| 25 | KOID | KRANESHARES TRUST | $0 | 0.00% | 0 | 清仓 |
来源：SEC 13F 申报文件 · 截至 2025-12-31
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR